Hemforce 6 X Liquid is a Health Canada–registered human drug (DIN 02233623) held by Bio Active Canada Ltd., containing Quinine Sulfate. Health Canada lists its status as Cancelled Post Market (status date 28 Sep 2007). Nexara Health has matched 72 registrations of Quinine Sulfate across 9 other regulated markets.
Health Canada registration
| DIN | 02233623 |
|---|---|
| Brand name | Hemforce |
| Active ingredient | Quinine Sulfate |
| Strength | 6 X |
| Dosage form | Liquid |
| Route | Oral |
| Company | Bio Active Canada Ltd. |
| Status | Cancelled Post Market — 28 Sep 2007 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Quinine Sulfate registered in other markets
72 registrations of the same molecule in 9 national registries outside Canada (first 31 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Australia | Quinate | Rw | Tablet containing quinine sulfate dihydrate 300 mg | GE | PBS | |
| Bolivia | Quinina (bisulfato o sulfato) | — | 300 mg | Comprimido | LINAME (formulary) | |
| Hong Kong | Quinine Sulphate Tab 200mg S.c. | Teva Pharmaceutical Hong Kong O/B Teva Pharmaceutical Hong Kong Limited | Registered | DH Drug Office | ||
| Ireland | Quinine Sulphate 300 mg film coated tablets | Teva B.V. | Film-coated tablet | Marketed | HPRA | |
| Malta | Quinine Sulphate 300mg Coated Tablets | Wockhardt UK Limited | Coated Tablet | Withdrawn | Medicines Authority | |
| South Africa | Adco-quin dihyd 1 ml | Adcock Ingram Limited | 300 mg | Inj | S4 | DoH SEP database |
| South Africa | Quinine Adco | Adcock Ingram Limited | 300 mg | Tab | S4 | DoH SEP database |
| Taiwan | Quinidini Sulfas | Hamari Chemicals Ltd. | （粉） | 已註銷 | TFDA | |
| Taiwan | Quinine HCl Capsules "J.s." | 人生製藥股份有限公司 | 膠囊劑 | Registered | TFDA | |
| Taiwan | Quinine Hydrochloride | Pharmacie Centrale De France | （粉） | 已註銷 | TFDA | |
| Taiwan | Quinine Hydrochloride | Bandoengsche Kininefabriek Holland N.v. | （粉） | 已註銷 | TFDA | |
| Taiwan | Quinine Hydrochloride | Hoei Pharmaceutical Co. Ltd. | （粉） | 已註銷 | TFDA | |
| Taiwan | Quinine Hydrochloride "Alps" | Alps Pharmaceutical Co. Ltd. | （粉） | 已註銷 | TFDA | |
| Taiwan | Quinine Hydrochloride "Boehringer Mannheim" | Boehringer Mannhein GmbH | （粉） | 已註銷 | TFDA | |
| Taiwan | Quinine Hydrochloride "Lake" | Lake & Cruickshank Ltd. | （粉） | 已註銷 | TFDA | |
| United Kingdom | Quinine hydrochloride 125mg/5ml oral solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Quinine hydrochloride 125mg/5ml oral suspension | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Quinine hydrochloride 150mg/5ml oral solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Quinine hydrochloride 150mg/5ml oral suspension | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Quinine hydrochloride 200mg/5ml oral solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Quinine hydrochloride 200mg/5ml oral suspension | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Quinine hydrochloride 300mg/5ml oral solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Quinine hydrochloride 300mg/5ml oral suspension | — | 0001 | NHS dm+d VMP | ||
| United States | Chininum sulphuricum | Boiron | Pellet | listed | FDA NDC | |
| United States | Chininum sulphuricum | Boiron | Pellet | listed | FDA NDC | |
| United States | Chininum sulphuricum | Boiron | Pellet | listed | FDA NDC | |
| United States | Chininum sulphuricum | Boiron | Pellet | listed | FDA NDC | |
| United States | Chininum sulphuricum | Boiron | Pellet | listed | FDA NDC | |
| United States | Chininum sulphuricum | Boiron | Pellet | listed | FDA NDC | |
| United States | Quinine Base | Buchler GmbH | Powder | FDA NDC | ||
| United States | Quinine Hydrochloride | Buchler GmbH | Powder | FDA NDC |
See every manufacturer of Quinine Sulfate worldwide →
Regulator price references for Quinine Sulfate
Published list or reimbursement prices for Quinine Sulfate presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Australia | Quinate | Tablet containing quinine sulfate dihydrate 300 mg | 9.30 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| South Africa | Adco-quin dihyd 1 ml | 300mg | 10 | 584.97 ZAR | single exit price | DoH SEP database | 2026-09-01 |
| South Africa | Quinine Adco | 300mg | 100 | 589.02 ZAR | single exit price | DoH SEP database | 2026-09-01 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Hemforce (DIN 02233623) marketed in Canada?
No. Health Canada lists DIN 02233623 as Cancelled Post Market as of 28 Sep 2007.
Who holds the Canadian licence for this product?
Bio Active Canada Ltd. is the company of record in the Health Canada Drug Product Database.
Is Quinine Sulfate registered outside Canada?
Yes — Nexara Health has matched 72 registrations in 9 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02233623, status date 2007-09-28; national medicine registries: DH Drug Office, DoH SEP database, FDA NDC, HPRA, LINAME (formulary), Medicines Authority, NHS dm+d VMP, PBS, TFDA; price sources: DoH SEP database, PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02233623, status date 2007-09-28; national medicine registries: DH Drug Office, DoH SEP database, FDA NDC, HPRA, LINAME (formulary), Medicines Authority, NHS dm+d VMP, PBS, TFDA; price sources: DoH SEP database, PBS.
Health Canada Drug Product Database (DPD), DIN 02233623, status date 2007-09-28; national medicine registries: DH Drug Office, DoH SEP database, FDA NDC, HPRA, LINAME (formulary), Medicines Authority, NHS dm+d VMP, PBS, TFDA; price sources: DoH SEP database, PBS. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.